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Abstract: We are witnessing tremendous advances in our understanding of the organization of life. Complete genomes 
are being deciphered with ever increasing speed and accuracy, thereby setting the stage for addressing the entire gene 
product repertoire of cells, towards understanding whole biological systems. Advances in bioinformatics and mass spec-
trometric techniques have revealed the multitude of interactions present in the proteome. Multiprotein complexes are 
emerging as a paramount cornerstone of biological activity, as many proteins appear to participate, stably or transiently, in 
large multisubunit assemblies. Analysis of the architecture of these assemblies and their manifold interactions is impera-
tive for understanding their function at the molecular level. Structural genomics efforts have fostered the development of 
many technologies towards achieving the throughput required for studying system-wide single proteins and small interac-
tion motifs at high resolution. The present shift in focus towards large multiprotein complexes, in particular in eukaryotes, 
now calls for a likewise concerted effort to develop and provide new technologies that are urgently required to produce in 
quality and quantity the plethora of multiprotein assemblies that form the complexome, and to routinely study their struc-
ture and function at the molecular level. Current efforts towards this objective are summarized and reviewed in this con-
tribution. 
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INTRODUCTION 
  Protein-protein interactions (PPIs) are intrinsic to virtu-
ally every essential process in the cell. Deciphering PPIs is 
imperative for understanding the underlying biological 
mechanisms of living systems. Cellular activities that govern 
health and disease, such as DNA replication, transcription, 
splicing, translation, secretion, cell cycle control, signal 
transduction and intermediary metabolism are controlled by 
PPIs [1-5]. New developments in sequencing technology in 
combination with advances in affinity purification tech-
niques and automation are presenting researchers with the 
opportunity to study the proteome of various organisms at an 
ever increasing pace. Genome-wide protein-protein interac-
tion studies involving affinity chromatography and mass 
spectrometry (MS) analyses of systematically tagged open 
reading frames (ORFs) have been developed and imple-
mented, aided by powerful bioinformatics approaches, to 
address the entirety of PPIs in cells. 
  To date, many thousands of PPIs are known, however, 
the precise molecular details are available for only a small 
fraction of these interactions. Structure elucidation can ulti-
mately turn abstract system representations into models that 
more accurately reflect biological reality. The utility of struc-  
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tural biology is to understand the mechanisms governing 
biological interactions in living systems for designing strate-
gies to modulate, and interfere with these interactions. How-
ever, the large and increasing body of data describing PPIs 
on a genome-wide scale, and the pace at which it is amassed, 
is currently at a pronounced disparity with the rate at which 
the structure and function of representative protein com-
plexes that comprise the identified interactions, are described 
at the molecular level. Despite considerable advances in con-
temporary structure determination techniques and significant 
efforts by structural genomics consortia to streamline the 
process leading to high-resolution structures, many bottle-
necks in the structure determination pipeline remain.  
  Protein complexes are often found in scarce amounts in 
their endogenous host and remain difficult to isolate in the 
quantity and quality required for detailed functional and 
structural analysis. This is often the case already for electron 
microscopy experiments, although the requirements of this 
technique in terms of sample quantity are typically less im-
posing as compared to studies for example by X-ray crystal-
lography or by nuclear magnetic resonance (NMR) spectros-
copy. The latter two are the currently most powerful and 
widely used techniques for providing high-resolution struc-
tural information. Multiplexed overexpression experiments 
by using advanced recombinant production technologies 
could be instrumental not only for overcoming the sample 
production bottleneck, but also for compellingly validating 
proposed interactions in a heterologous setup. Streamlined 
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protein complexes, however, have been utterly lacking to 
date. New developments are required to rapidly and repro-
ducibly construct large protein complexes and variations 
thereof at the rate that they are conceptualized from genome-
wide studies.  
DECIPHERING THE INTERACTOME 
  In recent years, new and powerful methods have been 
developed which allow complex cellular protein-protein in-
teraction networks to be mapped (Fig. (1)). Such techniques 



























Fig. (1). Interactomics. Recent technological advances in genome-wide methods enable researchers to address protein-protein interactions 
present in the proteome of organisms in a comprehensive fashion, thus giving rise to the interactome. Native purification of proteins present 
in organelles and entire cells by using tandem affinity purification (TAP) methods, Strep-protein interaction experiment (SPINE) and trans-
genomics involving bacterial artificial chromosomes for generating stable mammalian cell lines, as well as protein-protein screens by yeast 
two-hybrid (Y2H) methods are supported by bioinformatics analyses, and together provide a (growing) picture of the interactome as a com-
plex mixture of multiprotein assemblies. Mass spectrometry (MS) based proteomic methods including matrix-assisted laser desorption ioni-
zation (MALDI) and electro-spray ionization (ESI) techniques coupled to liquid chromatography (LC-MS) and tandem MS-MS measure-
ments add to the catalogue of tools employed to tackle the complexome. The link between ineractome research and structural biology is 
made by native mass spectrometry. Native MS can provide vital information about the structure, topology and architecture of protein 
complexes preserved in the gaseous phase. Ion mobility separation coupled to mass spectrometry (IM-MS) and collision induced dissociation 
(CID) are new approaches holding particular promise for characterizing the properties and composition of even very large protein complexes. 
Recombinant overproduction, functional characterization and eventually 3-D structure determination can help to validate the vast amounts of 
interactome data from recent systems biology efforts. Multiplexed and quantitative MS methods in conjunction with limited proteolysis may 
become critically important to elucidate variants of recombinantly overproduced multiprotein complexes amenable to high-resolution struc-
tural and functional analysis. Combinatorial multigene generation, parallel small-scale expression and biochemical and biophysical analysis 
of multiprotein complexes derived from interactome data constitute likely modules of a conceptual “complexomics“ pipeline in analogy to 
current structural genomics approaches, leading to routine and rapid elucidation of the molecular architecture of many complexes and their 
subunit components by X-ray diffraction analysis, electron microscopy and NMR spectroscopy. 560    Current Genomics, 2009, Vol. 10, No. 8  Nie et al. 
sphere of research designated “interactomics”. The term “in-
teractome” is used to describe all known interactions present 
in the cellular gene product repertoire [6].  
Purification from Native Source 
  A celebrated development in high-throughput identifica-
tion of protein complexes is the tandem affinity purification 
(TAP) method [7]. In this approach endogenously tagged 
proteins of interest are produced which are used as bait to 
fish out interacting partners. The original TAP tag comprises 
two affinity tags: the Z-domain of protein A, which binds to 
immunoglobulin G (IgG), and calmodulin-binding peptide 
(CBP), which binds to calmodulin. These two tags are sepa-
rated by the highly specific tobacco etch virus (TEV) prote-
ase site. TAP tagging involves a relatively mild extraction 
procedure in which protein complexes are purified via a two-
step process that yields intact protein complexes composed 
of the tagged bait and any associated partners. This method 
is particularly useful for detecting stable complexes; more 
transient complexes are not observed, as they tend to disso-
ciate during purification. Two major proteome-wide studies 
in S. cerevisiae using the TAP method have revealed many 
previously unknown protein interactions and pathway asso-
ciations [8, 9]. In one study, Gavin et al. TAP-tagged 6406 
ORFs from the S. cerevisiae genome which enabled the puri-
fication of 1993 tagged proteins and the identification of 491 
protein complexes [8]. In an independent study, Krogan et 
al. TAP-tagged 4562 ORFs from the yeast proteome. 2357 
of these TAP-tagged proteins were purified revealing 547 
complexes as well as 429 interactions between complexes 
[9]. In both of these extensive studies affinity tags were in-
troduced into the 3’ ends of target ORFs in the yeast chro-
mosome by homologous recombination.  Data generated 
from these surveys correlated well with known protein com-
plexes formerly discovered and studied by conventional 
means. More notably, new interaction partners of well-
known complexes were identified, as well as entirely novel 
complexes and associations.  
  Methods to optimize the TAP tagging strategy are under 
way in an effort to obtain larger quantities of tagged protein 
assemblies. One of the challenges of the TAP method is to 
gain insight into the more fleeting interactions present in a 
protein complex. Herzberg et al. have developed a Strep-
protein interaction experiment (SPINE) that deals with the 
inherent false positives otherwise found in TAP tagging ex-
periments [10]. By replacing the TAP tag with a strongly 
interacting variant of Streptavidin called Strep-tactin and 
employing a reversible cross-linking reagent, Herzberg et al. 
were able to get an in vivo snap-shot of bait interactors in B. 
subtilis in a single affinity purification step. 
  In the years since the pioneering initial glimpses into the 
yeast interactome, subsequent affinity purification studies 
have sought to shed light on the interactomes of multicellular 
organism. Multicellular organisms are generally less amena-
ble to TAP-tagging approaches due to the challenge of using 
homologous recombination to insert affinity tags and the 
difficulties in retrieving sufficient quantities of purified ma-
terial. Nevertheless, Cheeseman et al. described a procedure 
using the TAP tagging principle to purify protein complexes 
from C. elegans strains and cultivated HeLa cells [11]. By 
modifying the TAP tag to include green fluorescent protein 
(GFP) followed by the Z-domain of protein G instead of pro-
tein A, and by replacing the CBP-tag with streptavidin pep-
tide, this study revealed intact complexes involved in C. ele-
gans kinetochore formation. 
 Furthermore,  Burckstummer  et al. overcame the problem 
of low protein yields in TAP tagging experiments in mam-
malian systems by likewise altering the composition of the 
TAP tag [12]. They also replaced the IgG peptides of Protein 
A with those of Protein G and the CBP peptide with strep-
tavidin peptide. Using IKK with this modified TAP tag as 
bait resulted in a ten-fold increase not only in the amount of 
bait but also of its interacting partner, IKK. These ad-
vancements in affinity purification techniques promise to 
allow future interactome maps of cultivated human cell lines 
to be determined, as well as maps of other cell types that are 
inherently more difficult to cultivate in large quantities, such 
as neuronal cells and immune cells. By tweaking certain as-
pects of existing purification strategies, such as modifying 
the original TAP tag itself, high-throughput interactome 
maps are moving into the realm of mammalian systems. 
  An interesting approach called BAC TransgeneOmics 
was recently described as a tool for studying protein-protein 
and protein-DNA interactions in addition to protein localiza-
tion [13]. BAC TansgeneOmics describes a method by 
which all known proteins within a proteome of a given orga-
nism are tagged on a genome-wide scale. Using this recom-
binantly tagged genome to create a bacterial artificial chro-
mosome (BAC) library ensures the presence of native regu-
latory regions around the target gene. BACs containing the 
recombinantly tagged genes of interest are then sequentially 
transfected and expressed in mammalian cells. The tags con-
sist of a combination of fluorescent proteins and peptides for 
affinity purification and reporting on factors such as in vivo 
protein localization and endogenous protein interactions. 
Interaction Analysis by Yeast Two-Hybrid Screens 
  Another powerful method for generating interactome 
maps in a high-throughput manner is the yeast two-hybrid 
(Y2H) approach [14]. Interactome-wide binary interaction 
maps resulting from Y2H screens are generally regarded as 
low-coverage studies, noisy and containing a high likelihood 
of false positives. In an attempt to systematically map inte-
ractome networks from Y2H screens, Venkatesan et al. esti-
mate that only 8% of the full human interactome has been 
covered by Y2H screens [15]. However, these surveys conti-
nue to provide a useful concomitant view of the whole inte-
ractome when considered alongside other affinity purificati-
on/MS-based techniques [5]. Y2H screens report on whether 
or not two proteins interact by fusing to a target protein the 
DNA binding domain (DBD) of a transcription factor while 
potential binding partners are fused to an activation domain. 
Any interaction between the two target proteins leads to the 
expression of a reporter gene [16]. There are three common-
ly used high-throughput Y2H screening approaches: (1) the 
yeast mating approach in which haploid DBD strains and 
strains with the activation domains undergo mating and se-
lection for reporter expression; (2) the matrix approach, whe-
re DBD strains can be mated with an array of strains contai-
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involves the mating of individual DBD strains with a library 
of activation domain strains that represents a cDNA library 
of a given target organism [5]. The latter method is the most 
efficient for high-throughput studies, however, the sampling 
efficiency of individual DBD strains with entire cDNA libra-
ries is greatly reduced.  
  While the Y2H strategy has the capacity to meet the de-
mands of high-throughput interactome mapping, this appro-
ach cannot currently compete with affinity based methods in 
terms of genome coverage. Nonetheless, Y2H surveys have 
realized a rich source of high-quality binary interaction maps 
from a wide range of organisms, including viruses, bacteria 
[17], S. cerevisiae [14, 18, 19], D. melanogaster [2], C. ele-
gans [20-22] and humans [4, 23, 24]. It is also important to 
note that while Y2H screens are critisized for inherent prob-
lems concerning the overexpression of homologous genes, 
the post-translational modification machinery and a bias to-
wards interactions that occur in the nucleus, this approach 
can examine a different subspace of the protein interaction 
world to that sampled by affinity/MS methods. Together, 
both sources of interactome mapping provide a more 
comprehensive outlook of the whole interactome. 
  Two valuable high-throughput Y2H human PPI maps 
were generated by Stelzl et al. [24] and Rual et al. [4]. These 
independent studies both utlized the matrix approach to a-
chieve greatest possible coverage of the human genome and 
between them identified approximately 6000 binary protein 
interactions. In the Stelzl study, where 4456 baits and 5632 
preys were screened, 195 disease related genes were found to 
interact with previously unidentified partners. Furthermore, 
342 uncharacterized proteins were assigned new putative 
roles after being found to interact with a protein of known 
function. In total, new functions were assigned to hundreds 
of different proteins. In a comparable effort, Rual and col-
leagues looked for binary interactions between approximate-
ly 8100 ORF’s and detected approximately 2800 protein 
associations. These interactions were then correlated with 
independant co-affinity purifications which revealed an over-
lap of approximately 78%. Despite the impact these Y2H 
screens have made in the field of interactomics, further deve-
lopments are still required before they reach the coverage 
achieved by affinity methods. The impact of these studies 
will surely propel the current technology in Y2H to new 
heights. 
  In a recent high-quality yeast binary protein interaction 
study, Yu et al. have attempted to deal with a long standing 
criticism that Y2H screens are biased towards interactions 
that occur within the nucleus [25]. To counter this concern, 
Yu et al. performed a Y2H screen in parallel with a yellow 
flourescent protein complementation assay (PCA) in which 
the traditional bait and prey peptides are replaced with non-
flourescing halves of yellow fluorescent protein (YFP). Once 
the interacting partners are in close proximity, the fluores-
cent properties of YFP are reconstituted and thereby create a 
useful marker that is not limited to reporting on interactions 
that occur within the nucleus. Using their dual method, Yu  
et al. were able to validate their own results, which showed a 
greater degree of correlation than that shown between the 
Gavin and Krogan TAP studies. Y2H screens are certainly 
becoming a valuable tool for studying genome-wide protein 
ineractions and will likely continue to make major contribu-
tions to the field of interactomics. 
Computational Approaches  
  Results from high-throughput interactome studies are 
being tabulated with increasing clarity. These efforts are 
resulting in unprecedented amounts of potentially useful data 
for molecular and structural biologists. On the bioinformatics 
side, the major hurdles in analyzing high-throughput interac-
tome data sets include managing databases, creating useful 
clustering algorithms to glean valuable information about 
protein interactions, and using the resulting clustering to 
make predictions about biological systems. Results from 
combined genome-wide interaction studies may contain only 
partially overlapping datasets, false positives (interactions 
that should not normally occur in a cell) and false negatives 
(limited or biased coverage that excludes a true interaction). 
Such issues hamper a comprehensive portrayal of protein 
networking [26]. Today’s bioinformatician faces many chal-
lenges in the emerging field of interactomics. What follows 
is an overview of what challenges are being faced currently 
and those that are on the horizon that will undoubtedly con-
tinue to be a boon for structural biologists in search of com-
plex three dimensional (3-D) structures.  
  Considering that each genome-wide interactome study   
generates characteristic data and that each existing repository  
uses characteristic file formats for storing data, the challenge  
of creating a consolidated resource for a transparent flow of  
data between datasets is startling. The Molecular Interactions  
(MI) group of the Proteomics Standards Initiative (PSI) has  
created an international standard for representing protein   
interaction data by consolidating existing interactome data   
sets from individually curated databases to create the Inter- 
national Molecular Interaction Exchange consortium (IMEx)  
[27]. The consortium, to date, includes the following data- 
bases: DIP (http://dip.doe-mbi.ucla.edu), IntAct (http://www.  
ebi.ac.uk/intact), MINT (http://mint.bio.uniroma2.it/mint),   
MPact (http://mips.gsf.de/genre/proj/mpact), MatrixDB   
(http://www.matrixdb.ibcp.fr), BioGRID (http://www.the- 
biogrid.org), MPIDB (http://www.jcvi.org/mpidb) and BIND  
(http://www.blueprint.org). Alongside IMEx is MIMIx, the  
minimum information required for reporting a molecular   
interaction experiment. MIMIx tackles the lack of commu- 
nity consensus on what information is required to report mo- 
lecular interaction by setting up an international standard to  
facilitate the extraction of useable data from PPI experiments  
by users. Currently, data is exchanged in XML format.  
  A major challenge concerning interactome datasets is 
how to cluster the resulting interactions to accurately report 
on real protein complexes rather than spurious, or false posi-
tive interactions while including more transient members of 
protein complexes rather than only architectural ones. Based 
on the Gavin, Krogan and Ho studies, Hart et al. used an 
unsupervised probabilistic scoring scheme and assigned con-
fidence scores to each interaction. This approach generated a 
matrix-model interpretation of the yeast interactome datasets 
[28]. Unsatisfied with the existing spoke model as a way of 
representing interactome data which only considers bait and 
prey interactions, Hart and colleagues devised a scoring 
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takes prey/prey interactions into account, thereby including 
the elusive transient members of complexes without decreas-
ing the overall accuracy of reported complexes. In doing so, 
it was shown that the degree of overlap between the reported 
datasets was considerably higher than previously thought, 
and that one of the major problems in previous comparisons 
was the inclusion of ribosomal protein interactions. Based on 
assessments of similarity between the above mentioned 
datasets and with a third yeast interactome dataset [9], Hart 
et al. suggested that these studies are approaching saturation 
of what can be known about the subset of the complexome 
of yeast grown in rich media. Recently, Krogan indicated 
that a rough calculation based on the overlap of the two stud-
ies suggests that approximately 80% of the interactions ca-
pable of detection in yeast by the TAP method have been 
detected [29]. 
  Another consequence of the upsurge in PPI maps and 
genome-wide sequencing efforts is the new wealth of data 
that can be used by the community of scientists who model 
protein interactions and predict protein function from the 
gene sequence. With the ever increasing amounts of data 
about PPIs, it is possible to identify recurring ‘domain signa-
tures’ and to correlate frequent interactions between them, 
the idea being that the interaction may be mediated by the 
signature sequence [30]. Knowledge about where an interac-
tion might occur can also narrow down which portions of a 
protein sequence should be included in designing protein 
complex constructs [31]. 
Mass Spectrometry 
  Mass spectrometry (MS) has emerged as an indispen-
sable tool for studying the interactome [32, 33]. MS is now 
firmly established as one of the main driving forces of prote-
ome studies, and is increasingly the method of choice for 
analyzing complex protein mixtures derived from entire 
cells. Besides protein identification, quantification and profi-
ling, MS has had a significant impact on the analysis of pro-
tein interactions and protein complexes [32]. Combining 
affinity purification with MS allowed a de novo characteriza-
tion of the composition and organization of the cellular ma-
chinery. Data derived from these methods indicated that 
complexes can combine transiently and differentially in a 
modular fashion thus enabling a diversification of the poten-
tial function of individual protein complexes [8]. MS-based 
interactome analysis approaches, using a variety of techni-
ques including matrix-assisted laser desoprtion/ionization 
(MALDI) and liquid-chromatography coupled electro-spray 
ionization (LC-MS), offer several important advantages for 
studying protein complexes as compared to other techniques. 
A protein complex can be isolated directly from its cellular 
environment, fully processed with its full complement of 
modifications and directly studied by MS without the need 
for further manipulations [34]. MS based methods can readi-
ly detect stable interactions which constitute core architectu-
res of protein complexes. Implementation of chemical cross-
linking strategies in MS experiments further offers possibili-
ties to detect and analyze important transient interactions 
[35]. A key issue is the analysis of the vast amount of data 
gathered in MS-based proteome and interactome analysis. 
Progress is being made in developing tools for analyzing 
MS-data based on statistical principles [36, 37]. 
  MS experiments can likewise be used to obtain invento-
ries of biochemically isolated organelles allowing for the 
characterization of sub-interactomes contained within sub-
cellular compartments. High-resolution methods were ap-
plied for accurate protein identification and novel algorithms 
were developed to assign genuine components from co-
purifying proteins in these experiments [38]. This holds par-
ticular promise for accessing the protein repertoire and 
complexome of such cellular subcompartments by high-
resolution structural and functional studies. 
  MS based interactome wide studies are often met with 
skepticism concerning the reproducibility of results [39]. The 
Test Sample working group of the Human Proteome Organi-
zation (HUPO), who have an interest in establishing interna-
tional standards for proteomics studies, attempted to address 
the question of irreproducibility in MS experiments. The 
working group provided a defined test sample containing an 
equimolar mixture of highly purified recombinant proteins to 
27 different laboratories using high-throughput MS methods 
to test their ability to correctly identify the mixture [40]. The 
results were that, initially, only a quarter of the laboratories 
correctly identified the protein mixture. However, upon clo-
ser inspection of each laboratory‘s raw data, it became appa-
rent that the peptides had in fact been identified in every case 
and that the problem arose in environmental contamination 
of the sample, incorrect database matching and poor curation 
of proteins identified. In summary, this study exemplified 
that reproducibility in MS experiments can be achieved by 
carrying out the MS experiments with care and by upgrading 
existing databases for their curation [39, 40]. 
  The link between interactome research and structural 
biology is made by native mass sepctrometry of large protein 
assemblies, an emerging, very promising technology. Native 
mass spectrometry techniques allow sensitive analyses of 
endogenously expressed protein complexes with high speed 
and selectivity [41, 42]. Importantly, native MS can provide 
vital information about the structure, topology and architec-
ture of protein complexes. Protein complexes in native MS 
experiments are prevented from disassociating in the gaseous 
phase during electro-spray ionization (ESI). Additionally, 
nanoflow ES (nano-ES) is employed for improved resolution 
of the sample being studied thereby improving the sensitivity 
of native MS [40]. High-perfomance mass analyzers, such as 
orthogonal ESI-time of flight (TOF) instruments, can be u-
sed to accurately identify ions with a high mass-to-charge 
ratio, a prerequisite for analyzing large protein complexes 
with many subunits by native MS [42]. Tandem MS-MS 
methods, usually used in proteomics experiments to deduce 
the amino acid sequences of small peptides, can be applied 
to native MS to gather information about the subunits pre-
sent in a protein complex [40]. Apparently, peripheral subu-
nits are preferentially eliminated in this setup, thus allowing 
interpretation of the topology of the complexes analyzed.  
  A recent technological advance is ion mobility seperation 
coupled to mass spectrometry (IM-MS), which has been par-
ticulary useful to establish mass spectrometry as a powerful 
tool for structural biology applications [41, 43]. In IM-MS, 
ions are separated on the basis of their mass-to-charge ratio 
and as well on their drift time in a gas-filled ion mobility 
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molecule, with larger molecules exhibiting longer drift-
times, thus allowing determination of the average projection 
area of a specimen studied. It is conceivable that this techni-
que will mature into a tool that will be routinely used to 
measure the cross-section of large protein complexes, which 
could be rather useful for providing volume constraints that 
can be utilized in molecular modelling of these assemblies 
[43]. 
  Requiring relatively small amounts of protein sample 
compared to other MS techniques, nanoelectro-spray ioniza-
tion can achieve the maintenance of a solution structure in 
the gas phase. Using collision-induced dissociation (CID), 
even very large protein complexes can be selectively disso-
ciated by collision with neutral gas atoms. Each collision 
event results in the accumulation of internal energy by the 
ion in question. Upon accumulation of sufficient internal 
energy, this ion may undergo dissociation. This approach can 
be used to dissociate protein complexes into subcomplexes 
and subunits which are then analyzed with TOF instruments. 
CID has been used to analyze virus capsids and entire ribo-
somes with a molecular mass of 2.5 MDa [44]. The complete 
subunit architecture of the yeast exosome, the protein ma-
chine which degrades RNA in yeast, could be correctly as-
signed using CID [45]. Furthermore, subcomplexes and pe-
ripheral subunits of human elongation factor elF3 could be 
identified by using this method [46, 47]. 
IMPACT OF STRUCTURAL GENOMICS 
  The description of the 3-D structure of biological mac-
romolecules, at near-atomic resolution, is imperative for un-
derstanding their function at the molecular level. The eluci-
dation of the DNA sequence of the entire genome of many 
organisms, including humans, revealed the gene repertoire 
present in cells. This set the stage to address the proteome, 
which is the comprehensive assemblage of all known gene 
products in an organism. The elucidation of the 3-D structure 
of all encoded proteins, at high resolution, is the goal of 
structural genomics efforts. Structural genomics aims at 
building up a high-resolution library dedicated to catalogu-
ing the protein complement of different organisms via high-
throughput and automated approaches starting from molecu-
lar cloning of the genes to structure elucidation of the en-
coded proteins. Based on structures deposited in the Protein 
Data Bank (PDB), structure determination by single crystal 
X-ray diffraction analysis is currently the predominantly 
used technique, in addition to structure determination in so-
lution by NMR. By means of comparison with structures of 
well-characterized proteins and domains, the biological func-
tion of uncharacterized proteins can often be discovered or 
proposed. Until the beginning of 2008, the combined effort 
from structural genomics consortia worldwide contributed 
about 50% of the newly-deposited structures in the PDB. 
One of the largest structural genomic projects is the Project 
Structure Initiative (PSI) in the United States, which is spon-
sored by the National Institute of Health (NIH). Several 
other large consortia exist in Japan, Canada, and Europe 
[48]. 
  In addition to the very large number of structures to be 
elucidated for describing a proteome, structural genomics 
approaches were confronted with a multitude of challenges. 
Successful structural determination by X-ray crystallography 
typically requires iterative optimization of protein encoding 
sequences for expression and purification of the specimens. 
Several to many expression vectors, host organisms and host 
strains need to be integrated into the experimental work-
flow, in addition to covering a large space of conditions suit-
able for crystallization. All steps involved require consider-
able investment in labor and materials and a very significant 
through-put of experiments. Entire proteomes are addressed 
most often at the single protein or protein domain level. 
Consequently, structural genomics intensively stimulated 
and fostered the implementation of automation and high-
throughput approaches, which now result also in consider-
able benefit for classical, hypothesis driven structural mo-
lecular biology. Many laboratories are now in the process of 
integrating high-throughput approaches at varying levels in 
their research [49].  
  Structural genomics projects generally start from target 
selection, which is based on evaluation of a large amount of 
candidate genes via bioinformatics methods. This is followed 
by cloning, insertion in one or several expression vectors, 
expression and purification, and finally structure determina-
tion. Researchers at centers engaged in structural genomics 
integrated automated cloning strategies based on restric-
tion/ligation [50, 51], ligation-independent cloning [52, 53], 
or recombination [54, 55]. Among them, recombination 
based cloning systems are most widely utilized in high-
throughput experiments. Although the systems used cur-
rently are robust and can be automated, they are often not 
sufficiently flexible when variations of expression elements 
such as purification tags, promoter/terminator combinations, 
protease cleavage sites and others need to be introduced or 
modified [49].  
  Autoinduction procedures were found to be particularly 
useful for automated high-throughput approaches for expres-
sion of the target specimens in E. coli as expression host. 
Autoinduction is based on a defined medium containing 
glycerol, glucose and lactose as inducer, which makes use of 
promoters containing lac operators. Glucose prevents induc-
tion by lactose until it is consumed. Upon glucose depletion 
in the culture, lactose is metabolized and heterologous induc-
tion occurs by means of the lac operator. Autoinduction thus 
simplifies the expression procedure: it alleviates the re-
quirement for monitoring the density of cell cultures, as glu-
cose depletion auto-regulates the time of induction. Further, 
auto-induction does not require the addition of inducer 
chemicals facilitating means for automation [56]. 
  Increasingly, cell-free (CF) protein synthesis methods 
emerge as a viable alternative to in vivo expression in struc-
tural genomics pipelines due to several advantages [57]. Pro-
teins that are toxic to host cells can be expressed by CF ex-
pression, and CF expression, in principle, can be better con-
trolled by using highly purified components [58]. CF expres-
sion is especially useful for structure determination by NMR 
spectroscopy, since it is performed in small volumes and 
therefore requires less isotope label than cellular protein la-
beling [48, 57]. CF methods may be particularly useful for 
efficient screening of detergents required for successful pro-
duction for membrane proteins [59], and may also allow 
rapid, small volume parallel screening of many variants of a 
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  Many particularly exciting targets in the proteome will 
require expression in eukaryotic systems. Baculovirus ex-
pression vector systems (BEVS) increasingly become the 
method of choice for many of these targets. While consider-
able effort is being invested into automation and high-
throughput protein expression by using BEVS [61-63], con-
trolled virus generation in sufficient quantity and quality 
remains a challenge with currently available BEVS tech-
nologies [61]. Transient transfection of plasmid DNA into 
the nucleus of insect cells was suggested as a possible, eco-
nomic alternative for analytical screening prior to larger 
scale virus generation [61].  
  Hierarchal multiplex expression and purification strate-
gies utilized by the core Protein Production Platform of the 
Northeast Structural Genomics Consortium (NESG), foster 
an increase in the production of protein samples and also the 
solution of many 3-D protein structures [55]. Initiatives are 
ongoing to set up productive modules for target sampling, 
cloning, sample characterization and crystallization, arranged 
into fully integrated pipelines [64]. Since compact globular 
domains defined by limited proteolysis are good candidates 
for production of diffraction quality crystals, high-
throughput limited proteolysis/mass spectrometry ap-
proaches for protein domain elucidation are being included 
into such pipelines, providing precise definition of domain 
boundaries, with significant impact for success prospects 
[65].  
  Structural genomics has decisively accelerated automa-
tion and the development of robust high-throughput meth-
ods. Nonetheless, critics claim that structural genomics con-
sortia have gone after the “low-hanging fruit”, such as solu-
ble single proteins of prokaryotic origin which are compara-
tively easy to express and purify [66]. Actually, structural 
genomics efforts now are gradually moving to address more 
challenging target proteins of eukaryotic origin. The objec-
tive is to facilitate the structural determination of human 
proteins, integral membrane proteins, and eventually multi-
protein complexes [48]. However, the currently implemented 
approaches for automation and high-throughput methods 
cannot easily accommodate the upgrade required to address, 
in particular, large and complex multicomponent systems. 
The automation currently implemented in cloning routines 
and expression systems are mainly designed for addressing 
single ORFs or small, mostly binary systems [67].  
EUKARYOTIC MULTIPROTEIN EXPRESSION: 
MULTIBAC 
  The interactome can not be rationalized on the basis of 
elucidating single protein structures. It is now increasingly 
clear that the proteins in the cell function as interlocking 
machines containing ten or more interaction partners, that 
associate stably or transiently to realize cellular activities [1]. 
Structural genomics efforts have provided a wealth of detail 
on the level of individual proteins and domains. To address 
the more complex challenge of multicomponent assemblies, 
a number of expression systems have been introduced, that 
are suitable for simultaneous expression of several genes in 
prokaryotic and eukaryotic hosts [68-72]. In spite of consid-
erable improvements of eukaryotic expression systems, E.  
 
coli still remains to date the expression system of choice in 
most laboratories. Nonetheless, eukaryotic expression is also 
being implemented for production of samples that can not be 
produced in E. coli. In particular the baculovirus/insect cell 
system has been streamlined significantly, and detailed pro-
tocols have become available that considerably simplify 
handling, thus alleviating some of the uncertainties regarding 
this system that impeded its routine application by non-
specialist users [70, 73, 74].  
  Our laboratory has contributed to some of these devel-
opments, with particular focus on the production of mul-
ticomponent protein complexes for structural biology appli-
cations. We are interested in the structural molecular biology 
of eukaryotic complexes. For recombinant overproduction of 
these complexes, a system for multiprotein expression in 
insect cells, called MultiBac, was introduced [70, 73] (Fig. 
(2)). MultiBac uses an engineered deletion baculovirus with 
improved protein production properties including reduced 
proteolysis and a delayed onset of cell fragmentation in the 
late phase of viral infection [73]. This MultiBac baculovirus 
is accessed by two plasmids called transfer vectors at two 
recombination sites present on the virus: a LoxP imperfect 
inverted repeat for site-specific recombination, and a Tn7 
attachment site. The Tn7 attachment site is embedded in a 
LacZ gene for blue-white selection of recombinant bacu-
loviruses. These transfer vectors harbour the heterologous 
genes of interest. The MultiBac baculovirus exists as a BAC 
in  E. coli cells containing also a small plasmid with four 
genes encoding for the Tn7 transposon, similar to the widely 
utilized Bac-to-Bac system from Invitrogen, and essentially 
all other baculovirus systems that rely on Tn7 transposition 
of a transfer vector in vivo in an E. coli host strain.  
  The transfer vectors that we developed for MultiBac con-
tained elements that made it particularly straight forward to 
arrange into multigene expression cassettes several to many 
expression units containing ORFs encoding for example for 
members of a protein complex of choice. One transfer vector 
was designed to provide these multigene cassettes between 
Tn7L and Tn7R DNA sequences for integration into the Tn7 
site of the MultiBac baculovirus. A second transfer vector 
contained a LoxP sequence thus enabling integration of 
multigene cassettes into the LoxP site of the MultiBac virus 
in the presence of Cre recombinase, the enzyme responsible 
for fusing DNA pieces that contain the imperfect inverted 
repeat. Integration into the LoxP and Tn7 site could be car-
ried out simultaneously by co-transfecting the two transfer 
vectors into E. coli cells harboring the MultiBac virus, and 
expressing Tn7 transposon and Cre recombinase, respec-
tively, from helper plasmids [73]. Selection for recombinant 
MultiBac viruses harboring the multigene cargo occurred via 
blue/white selection and antibiotic challenge for the resis-
tance marker contained in the plasmid incorporated into the 
virus by Cre-LoxP fusion (Fig. (2)).  
  The MultiBac system as conceived in 2004 was surpris-
ingly well received in the community, probably indicating 
the present and growing interest in researching eukaryotic 
interactomes and multiprotein complexes. Many laboratories 
requested the MultiBac reagents, many proteins were ex-




















Fig. (2). MultiBac BEVS: Eukaryotic multiprotein expression. ORFs (a-e) encoding for subunits of a protein complex and auxiliary pro-
tein such as modifiers or chaperones, are inserted into a plasmid containing the sequences required for Tn7 transposition (Tn7L, Tn7R), or a 
plasmid containing a LoxP imperfect inverted repeat, respectively. Gene insertion occurs via a multiplication module (small rectangles) de-
signed for facilitating multigene cassette generation. A baculovirus genome containing the Tn7 attachment site (attn7) and a LoxP sequence, 
in addition to deletions beneficial for protein production, is present in bacterial cells in form of a bacterial artificial chromosome (BAC). Inte-
gration of multigene expression cassettes is mediated by the Tn7 transposon and Cre recombinase, respectively, which are expressed from 
helper vectors in the bacteria [73]. Transfection of insect cells with the resulting composite baculovirus results in high-level expression of the 
proteins in cultured insect cells. Adapted from [95]. 
produced by MultiBac are now being reported [75, 76]. In-
terestingly, our baculovirus expression technologies were not 
only used successfully for protein complex production for 
structural biology as they were designed for, but also for 
rather diverse other applications ranging from production of 
possible vaccine candidates based on papilloma virus like 
particles [77] to preparing recombinant adenoviruses for 
gene therapy treatment of obesity in laboratory rodents [78]. 
  In our view, the genuinely useful contribution in conjunc-
tion with MultiBac, was not only the creation of yet another 
baculovirus and a few transfer vectors. We had realized in 
the process of our experimental work that the parameters of 
virus generation are not really compatible with routine appli-
cation of an expression method in laboratories focusing on 
structural analysis. Baculovirus expression is constrained by 
certain requirements that need to be met to assure that the 
recombinant DNA cargo is properly maintained in the bacu-
loviral genome during virus amplification and eventually 
protein production [79-81]. We found that introducing a 
fluorescent marker gene into the virus backbone, and pre-
cisely monitoring fluorescence intensity as well as the cell 
growth development in a culture, provided a very useful and 
simple regimen to largely alleviate the detrimental loss of 
titer or loss of protein production which are the major im-
pediments encountered when using BEVS. This allowed us 
to establish a robust protocol for virus generation, amplifica-
tion and protein production which then could be applied rou-
tinely and successfully in our laboratory and many others 
including non-specialist users [74]. We feel that BEVS ex-
pression, by using these protocols, can now be performed 
with almost the same ease and effort, as heterologous ex-
pression is commonly carried out in E. coli.  
ACEMBLING MULTIPROTEIN COMPLEXES 
  The combination of many genes encoding for subunits of 
a protein complex into vectors used for expression will re-
main a rather laborious task, in particular if it relies on re-
striction digestion and pasting together of DNA fragments by 
ligase in a serial, one-gene-at-a-time mode. This approach is 
essentially refractory to automation. Structural genomics 
consortia have strived to address the problem by implement-
ing recombination methods for gene insertion. These meth-
ods have the advantage that they always use the very same 
reagents and reaction conditions, and therefore can be 
scripted into a robotics routine. The emphasis of most sys-
tems currently was mainly placed on offering a multitude of 
expression options for the one ORF of choice. For instance, 
the Gateway system from Invitrogen, defines an Entry vector 
for the gene of interest, which is inserted by any suitable 
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into a wide range of Destination vectors providing a large 
assortment of purification or solubility tags for expression in 
a variety of hosts. The situation presents itself in reverse for 
multiprotein complex expression: here, the challenge is to 
introduce an assortment of genes into probably one expres-
sion system of choice to start with. This needs to be achieved 
in a way that ideally, the genes encoding for the multiprotein 
complex to be studied can not only be assembled fairly eas-
ily, but also options need to be provided to modify the indi-
vidual subunit components rapidly and in a flexible way by 
mutation, truncation or replacing of affinity tags. Already for 
single proteins, altering the wild-type sequence for example 
by removing low complexity regions is often a prerequisite 
for successful high-resolution structural analysis, and intro-
ducing mutations is commonplace for elucidating the func-
tion and activity. This is equally valid for multiprotein com-
plexes, however, the tasks at hand are considerably more 
complicated to achieve as the number of interacting subunits 
increases. 
  These deliberations and underlying experimental necessi-
ties prompted us recently to introduce ACEMBL, an auto-
matable system for multiprotein expression making use of 
multigene recombineering by using a robot [82, 83] (Fig. 
(3)). For matters of simplicity, we first created ACEMBL in 
a version suitable for multiprotein complex production in E. 
coli as an expression host, although, the same robotic scripts 
can likewise be applied for generating multigene constructs 
for protein complex expression in eukaryotic hosts. We de-
cided to consequently adapt recombination methods at every 
step of the process of gene insertion and gene combination 
into multigene expression cassettes, and to implement al-
ready existing, robust robotics protocols for small scale ex-
pression and protein extraction by using affinity purification 
[82]. 
  Building on our positive experiences using Cre-LoxP 
fusion in MultiBac, we synthesized two families of small 
plasmids with the minimum DNA sequences required. These 
plasmids are called Acceptors and Donors. They are small 
(2-2.5 kb) and each plasmid contains the LoxP inverted im-
perfect repeat. Donors contain a conditional origin of replica-
tion which makes their existence and propagation in regular 
cloning and expression strains dependent on Cre-LoxP me-
diated fusion with Acceptors, which in turn have a regular 
origin of replication derived from the classical ColE1 origin.  
  We settled on sequence and ligation independent cloning 
(SLIC) as the method of choice for inserting genes into Do-
nors and Acceptors, as detailed protocols for this methods 
became available recently [84]. Nonetheless, we needed to 
modify and improve these protocols to achieve robust inte-
gration, in particular when the process was carried out on in 
a robotic setup using a liquid handling workstation [82, 83]. 
This SLIC method, and likewise the BD-InFusion (Clontech 
Takara) or standardized ligation independent cloning (LIC) 
methods (Novagen), are commonly referred to as recombina-
tion methods, although this denotion is slightly misleading 
for these approaches. Rather, these methods have in common 
that they make use of the 3’ exonuclease activity of DNA 
polymerases in the absence of nucleotide triphosphates. 
Thus, long single stranded overhangs are created which can 
serve as sticky ends if complementary single strands become 
available. Nicks are closed and gaps are filled by the E. coli 
machinery upon transformation with the annealed DNAs. 
We found that efficient procedures could be established for 
integrating single genes or polycistrons into the ACEMBL 
Donors and Acceptors by SLIC, and scripted into robust rou-
tines, which could be readily carried out by a robot [82]. 
Gene integration into the ACEMBL vectors occurs at inte-
gration sites that make up a so-called multiple integration 
element (MIE), which contains also restriction sites for con-
ventional gene integration as well as homing endonuclease 
sites for facile gene multiplication into multi-expression cas-
settes [82].  
  Donors thus charged with recombinant DNA cargo, each 
containing single genes, polycistrons or multiple expression 
cassettes, are then fused with one Acceptor by using Cre 
recombinase and the LoxP site present on each vector. Ac-
ceptors like Donors can contain one or several genes, poly-
cistrons or a combination thereof. Several Donors can be 
fused with each Acceptor. Selection for multiple resistance, 
each of these characteristic for one Donor or one Acceptor, 
then identifies the Donor-Acceptor fusions in a combinato-
rial fashion. By using this approach, we could easily gener-
ate in a single reaction a series of multigene expression vec-
tors expressing protein complexes as well as all possible 
combinations of genes contained on the individual vectors, 
revealing subcomplexes [82]. Interestingly, our experiments 
showed that multigene expression vectors could not only be 
assembled in this way, but likewise also selectively decon-
structed by using the reverse approach. This is achieved by 
applying  Cre recombinase to previously generated Donor-
Acceptor fusions. This is possible due to the equilibrium 
reached between the fusion and excision activities of the Cre 
enzyme. Thus, defined parts of a multigene construct, encod-
ing for subunits of a protein complex, can be excised by our 
procedure, altered for example by truncation, mutation, or 
replacement of the encoding genes, and then reintegrated 
into the multigene expression construct of choice by apply-
ing Cre fusion. This provides useful combinatorial options, 
also for robotics applications [82]. By employing the 
ACEMBL method, we were able to express and purify all 
members of the holotranslocon from E. coli, a large prokary-
otic translocation complex consisting of six transmembrane 
proteins, from a 16 kb multigene plasmid [82]. 
STRUCTURAL COMPLEXOMICS? 
  Genome and proteome-wide studies have clearly re-
vealed the key role of macromolecular complexes in most, if 
not all vital cellular processes. Protein complexes display 
activities that are entirely different from the activities of each 
subunit studied independently, as interaction partners often 
dramatically influence recognition propensities and likewise 
biological activities. In addition, protein complex composi-
tion in particular in higher eukaryotes can depend on tissue 
type and cell state. Importantly, covalent posttranslational 
modifications such as phosphorylation, acetylation, methyla-
tion and many others can have a critical impact on the forma-
tion of protein complexes and their activity. Due to all of the 
variables that need to be controlled when attempting to as-
semble protein complexes recombinantly, it is important to 
have a robust system that allows rapid testing of many dif-























Fig. (3). ACEMBL System. ACEMBL consists of newly designed, small vectors (A) and automated procedures and routines relying on re-
combineering for gene insertion and vector fusion (B). Multigene expression constructs are generated by insertion of genes into multiple inte-
gration elements (MIE) by recombination, followed by Cre-LoxP fusion of Donors with an Acceptor. Incubation of educt constructs (here 
pDK, pDS, pACE) containing genes of interest (white arrows) results in all possible combinations in a single reaction including Acceptor-
Donor (AD) and Acceptor-Donor-Donor (ADD) fusions as shown here schematically. Creation of even four-plasmid ADDD constructs has 
also been completed successfully in our laboratory [82]. All co-existing constructs have characteristic antibiotic marker combinations and 
resistance levels (right). Donor vectors contain a conditional origin of replication derived from R6K, and thus act as suicide vectors in clon-
ing strains devoid of the pir gene unless fused to an Acceptor with a regular replicon. A second Acceptor, pACE2, is identical to pACE ex-
cept for the encoded marker which confers resistance to tetracycline rather than ampicillin (not shown). Plasmid pACE2 can be used in con-
junction with pACE derivatives for example to co-express auxiliary proteins such as chaperones or modifiers [82]. (C) Recombineering 
workflow by using the ACEMBL system is shown. Genes are integrated in Donors or Acceptors by ligation independent methods such as 
SLIC followed by combinatorial multigene vector generation using Cre-LoxP fusion. Expression and purification provide protein complex for 
analysis. Multigene vectors are deconstructed by using Cre excision activity (De-Cre). Encoded genes are modified by PCR and reintegrated 
into the workflow by recombination in an iterative cycle. The entire process is compatible with automation, and was successfully scripted into 
a robotic routine. Adapted in part from [82, 83].  
  In the current environment, in which valuable informa-
tion about interactomes, complexomes and other genome-
wide studies is pouring in at an ever increasing pace, struc-
tural biology as it is performed to date simply cannot keep 
up with the increasing demand for the validation that only 3-
D structures can provide. Protein structures can offer insights 
into the details of a protein interaction at the molecular or 
near-atomic level, and it is imperative for structural biolo-
gists to move into the arena of protein complex interactions. 
Despite recent colossal efforts in obtaining 3-D structures at 
near atomic resolution by X-ray crystallography, greatly fos-
tered by structural genomics consortia, obtaining diffraction 
quality crystals of protein complexes remains a significant 
challenge and often takes on the order of years achieve. This 
technological state-of-the-art is simply incompatible with the 
speed at which new data is accumulated through high-
throughput research addressing the interactome, and a major 
effort towards the development of new technologies is ur-
gently required to close this gap. 
  3-D structural information can be gained from purified 
material extracted in small amounts from native source by 
electron-microscopic techniques which have significantly 
matured in recent years [85-87]. In particular, cryo-electron 
microscopy in conjunction with single-particle analysis can 
be used to gain information about the quaternary architecture 
of multiprotein assemblies. Although 3-D protein structures 
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resolutions than ever before, 3-D structures obtained by this 
method provide still limited information when compared to 
the atomic details obtained by X-ray crystallography or 
NMR spectroscopy.  
  Undoubtedly, great benefit could be derived from the 
development of advanced techniques and reproducible pro-
tocols for micropurification of endogenous complexes. Puri-
fication of protein from biological material present in limited 
amounts will certainly be necessary in particular for the iden-
tification of complexes, or variations of complexes, that are 
present in specialized cells or specific tissues, and for a thor-
ough validation of interactome data. This requires highly 
efficient methods to recover the quantities of protein re-
quired for biophysical methods. Due to the considerable in-
crease in sensitivity of mass spectrometers achieved in recent 
years, it is now possible to routinely identify subunits of pro-
tein complexes from pico- to femto-mole quantities of mate-
rial. It is critically important now to develop new strategies 
for the micropurification of protein complexes that will al-
low the simultaneous processing of several samples from 
limited amounts of source material. Such micropurification 
techniques, in conjunction with process automation for en-
dogenous sample preparation will decisively improve current 
research approaches both in terms of throughput and also 
quality of analysis. Size-exclusion chromatography (SEC) is 
often a rate limiting step in the preparation of protein com-
plexes. New purification strategies involving native gels, 
capillary electrophoresis or absorption onto membranes 
could possibly mature into genuine alternatives to SEC, thus 
allowing parallel processing of many samples and increasing 
sample homogeneity.  
  Recombinant expression most certainly had a decisive 
impact on life science research, and is to date the major 
technique for successful production of well-defined macro-
molecular specimens in the quality and quantity required for 
many applications. Apart from notable examples such as 
ribosomes or RNA polymerase [88-91], near-atomic struc-
ture determination of complex multicomponent systems will 
in all likelihood in most cases depend on recombinant over-
production. More recently, several multi-expression systems 
have been introduced for expression of protein complexes in 
a variety of different expression hosts, two of these were 
described in some detail in this contribution. However, most 
systems currently available still require dedicated expertise 
and considerable technical specialisation of the user, which 
is refractory to routine research, in particular for high-
throughput applications. Biological and also pharmaceutical 
research often depend on introducing variations (mutation, 
truncations, fusions with markers, etc) into the specimen 
studied. Multi-expression systems therefore must provide the 
flexibility required for rapid revision of experiments, where 
such alterations can be introduced with ease. The ACEMBL 
system we developed could represent a first step in this di-
rection. Nonetheless, production of many vital protein com-
plexes, especially those requiring a eukaryotic host machin-
ery for sample production, remains a challenge and a major 
bottleneck in the pipeline to high-resolution 3-D structures.  
  A further consideration in protein complex biology are 
those complexes that contain protein subunits as well as 
RNA components which may need to be co-expressed for 
proper complex assembly and folding. Protein-RNA com-
plexes such as telomerase, snRNPs or RNAi containing com-
plexes are a focus of contemporary research efforts aimed at 
elucidating mechanisms of health and disease. The recent 3-
D structure of a human spliceosomal U1 snRNP 
compellingly demonstrates the power of recombinant recon-
stitution of such a complex for structure elucidation [92]. 
Technologies allowing routine multigene expression in pro-
karyotic and eukaryotic hosts will certainly need to incorpo-
rate the means for producing heterologous complexes con-
taining non-protein components such as RNA and other bio-
molecules.  
  Automation is essential for accelerating contemporary 
protein science. Automation depends on standardization and 
simplification of protocols that are robust and reproducible. 
These requirements must be addressed by the development 
of easy-to-use, affordable reagents that are ideally compati-
ble with robotic procedures. Automation has already had a 
considerable impact on cloning, DNA preparation, protein 
purification by affinity tags and assaying protein activities. 
Protocols optimized for automation have at times superseded 
earlier, more laborious procedures even in laboratories not 
applying robots routinely, as manual procedures generally 
also benefit considerably from the standardization and ro-
bustness inherently required for methods that can be used by 
robots. Automation will be particularly important for recon-
stitution of macromolecular complexes by heterologous 
multigene expression as probably a large number of con-
structs will need to be tested for many cases until a satisfac-
tory reconstitution is achieved, yielding specimens suitable 
for detailed studies. The number of possible combinations 
increases dramatically with the number of subunits. This is 
particularly true if the pipeline is geared towards X-ray crys-
tallography. 
  In single crystal structure determination by X-ray diffrac-
tion, a vital prerequisite is the ability of a specimen to ar-
range into a highly ordered crystal lattice that diffracts the 
incident X-ray radiation to near-atomic resolution. Often, 
this challenge can only be met by introducing variation into 
the wild-type sequence until a crystallizable specimen is ob-
tained. Limited proteolysis, in conjunction with mass spec-
trometry, has been particularly useful for defining regions of 
low-complexity that can often interfere with crystallization. 
Such regions are then typically removed by introducing trun-
cations or deletions in encoding DNA sequences, and re-
combinant overexpression of the resulting variant can then 
result in sample more amenable to crystallization. Corre-
sponding procedures are now being introduced in more 
elaborate structural genomics pipelines. Nonetheless, it is 
clear that implementing such limited proteolysis procedures, 
often already laborious for single proteins, will be vastly 
more complicated when several to many ORFs need to be 
diversified concomitantly in a multiprotein complex. Recent 
advances in mass spectrometry, including quantitative, mul-
tiplexed techniques [93, 94] may prove to be invaluable for 
designing tools to analyze limited proteolysis experiments of 
complex multiprotein assemblies in high-throughput for 
structure elucidation.  
  High-resolution structure determination, in particular by 
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technology which can be readily applied to elucidate mo-
lecular function in near-atomic detail. While the field of X-
ray crystallography has achieved considerable advancements 
in recent decades, namely in the design of automated crystal-
lization platforms, robotics and greater access to high-
brilliance synchrotron radiation sources, there is still a con-
siderable distance to be covered before X-ray crystallogra-
phy can tackle the number of challenges presented by inter-
actome wide studies and complexomics. Miniaturization and 
standardization are now indispensable components of high-
throughput crystallization platforms. High-throughout meth-
ods will continue to provide many exciting possibilities for 
crystallization experiments aided by the arrival of technolo-
gies requiring unprecedented small amounts of sample for 
screening a very large space of crystallization conditions. 
Structural genomics consortia have played an indispensable 
role by installing automated pipelines for solving 3-D struc-
tures of individual proteins and protein domains. The dis-
covery of a vast plethora of multicomponent assemblies that 
form the interactome, their modifications, overlaps and 
variations poses a challenge for similar efforts that may ap-
pear seemingly unmanageable at the moment. What is now 
required is a concerted effort to advance current technologies 
as well as to develop and implement new methods and pro-
cedures for addressing the complexome of organisms.  
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ABBREVIATIONS 
BAC   =  Bacterial artificial chromosome 
BEVS   =  Baculovirus expression vector system 
CBP =  Calmodulin-binding  peptide 
CID =  Collision-induced  dissociation 
CF =  Cell-free 
DBD  =  DNA binding domain 
EM   =  Electron microscopy 
ESI =  Electro-spray  ionization 
GFP  =  Green fluorescent protein 
HUPO  =  Human Proteome Organization 
IM-MS  = Ion mobility seperation coupled to mass 
spectrometry 
kb   =  Kilobase 
kDa   =  Kilodalton 
LC-MS  =  Liquid-chromatography coupled electro-spray 
ionization 
LIC  =  Ligation independent cloning 
MALDI  =  Matrix-assisted laser desorption/ionization  
MIE  =  Multiple integration element 
MS =  Mass  spectrometry 
NMR =  Nuclear  magnetic  resonance 
ORF  =  Open reading frame 
PCR   =  Polymerase chain reaction 
PDB =  Protein  Data  Bank 
PPI =  Protein-protein  interaction 
SEC =  Size-exclusion  chromatography 
SLIC   =  Sequence and ligation independent cloning 
SPINE =  Strep-protein  interaction  experiment 
TAP  =  Tandem affinity purification 
TOF  =  Time of flight 
Y2H =  Yeast  two-hybrid 
YFP   =  Yellow fluorescent protein 
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